background
trend
stagebystag
increas
tumorspher
ts
format
glioma
sampl
report
despit
trend
surgic
specimen
give
rise
tss
even
world
health
organ
grade
iv
glioma
furthermor
report
differ
overal
surviv
primari
glioblastoma
patient
depend
propens
tumor
form
tss
howev
weight
fresh
specimen
vari
one
surgic
isol
next
method
accordingli
evalu
relationship
weight
surgic
specimen
grade
iv
glioma
capac
isol
tss
thirtyf
fresh
grade
iv
glioma
specimen
separ
two
group
base
whether
posit
neg
ts
isol
relationship
ts
isol
weight
surgic
specimen
assess
observ
signific
differ
weight
surgic
sampl
two
group
found
optim
weight
specimen
tss
isol
mg
thu
contrari
expect
abil
isol
tss
grade
iv
glioma
specimen
relat
weight
fresh
specimen
subpopul
glioblastoma
gbm
tumor
cell
possess
abil
undergo
neural
differenti
induc
tumorigenesi
cultur
appropri
condit
vitro
popul
tumor
cell
give
rise
gliomaspher
refer
gener
tumorspher
tss
tss
isol
variou
malign
tumor
includ
breast
prostat
bone
colon
kidney
lung
well
brain
previous
report
rate
isol
tss
increas
world
health
organ
grade
glioma
rise
moreov
possibl
isol
tss
gbm
specimen
case
report
isol
rate
estim
notabl
abil
isol
tss
signific
prognost
factor
overal
surviv
patient
primari
gbm
known
weight
fresh
specimen
vari
one
surgic
procedur
next
rais
question
whether
weight
specimen
determin
factor
abil
isol
tss
isol
protocol
suggest
specimen
weight
mg
need
isol
tss
howev
establish
experiment
relationship
weight
fresh
specimen
isol
tss
studi
assess
predict
valu
fresh
specimen
weight
determin
abil
isol
tss
test
hypothesi
greater
weight
specimen
effect
isol
tss
thirtyf
fresh
specimen
grade
iv
glioma
divid
two
group
base
abil
isol
tss
relationship
specimen
weight
tss
isol
studi
also
evalu
optim
cutoff
weight
specimen
isol
tss
patient
grade
iv
glioma
treat
institut
octob
august
includ
studi
tabl
patient
histolog
diagnos
accord
classif
grade
neuropathologist
molecular
properti
surgic
specimen
report
methyltransferas
mgmt
promotor
methyl
isocitr
dehydrogenas
idh
mutat
statu
assess
polymeras
chain
reaction
pcr
immunohistochemistri
ihc
case
ihc
result
neg
test
mutat
use
hotspot
techniqu
epiderm
growth
factor
receptor
egfr
loss
heterozygos
loh
chromosom
evalu
fluoresc
situ
hybrid
fish
identifi
ihc
fresh
tumor
specimen
obtain
oper
room
glioma
patient
undergo
surgeri
specimen
place
steril
centrifug
tube
spl
life
scienc
co
ltd
korea
ice
weigh
electron
precis
balanc
sartoriu
sartoriu
weigh
technolog
gmbh
goettingen
germani
within
h
thereaft
specimen
process
use
previous
report
mechan
dissoci
method
briefli
surgic
specimen
minc
dissoci
scalpel
dulbecco
modifi
eagl
mediumnutri
mixtur
mediatech
manassa
va
usa
pass
seri
nylon
mesh
cell
strainer
bd
falcon
franklin
lake
nj
usa
cell
suspens
wash
twice
cultur
complet
media
contain
supplement
invitrogen
san
diego
ca
usa
ngml
basic
fibroblast
growth
factor
bfgf
sigma
st
loui
mo
usa
ngml
epiderm
growth
factor
egf
sigma
uml
mgml
streptomycin
isol
singl
cell
cultur
gliomaspher
complet
ts
medium
consist
contain
ngml
bfgf
ngml
egf
antibioticantimycot
solut
gibco
invitrogen
korea
seoul
korea
cell
cultur
continu
three
six
passag
consist
statu
progenitorstem
cell
cell
morpholog
assess
observ
cultur
invert
phasecontrast
microscop
invert
microscop
olympu
tokyo
japan
neural
differenti
potenti
gliomaspher
subsequ
test
follow
evalu
abil
induc
tumorigenesi
vivo
relationship
isol
tss
weight
surgic
specimen
investig
optim
cutoff
weight
isol
tss
evalu
investig
surfac
intracellular
antigen
express
profil
tss
transfer
cover
slide
fix
paraformaldehyd
min
treat
ratio
methanol
acet
acid
min
cell
wash
permeabil
incub
triton
min
block
bovin
serum
albumin
bsa
amresco
solon
oh
usa
h
cell
incub
primari
antibodi
h
room
temperatur
follow
antibodi
use
rabbit
abcam
dawinbio
inc
hanam
korea
rabbit
antinestin
abcam
primari
antibodi
nestin
detect
goat
antirabbit
igg
conjug
alexa
fluor
invitrogen
spectral
similar
cell
mount
vectashield
mount
media
contain
dapi
vector
laboratori
burlingam
ca
usa
counterstain
nuclei
phosphatebuff
salin
pb
dawinbio
inc
hanam
korea
use
wash
step
antibodi
diluent
reagent
solut
invitrogen
use
dilut
antibodi
neg
control
secondari
antibodi
use
fluoresc
microscop
olympu
korea
seoul
korea
dp
control
softwar
olympu
korea
use
observ
photograph
cell
section
thick
deparaffin
xylen
rehydr
grade
alcohol
seri
distil
water
antigen
retriev
perform
microwav
irradi
sampl
incub
follow
primari
antibodi
rabbit
polyclon
abcam
dawinbio
inc
hanam
korea
mous
monoclon
antinestin
cell
marqu
rocklin
usa
mous
monoclon
dako
korea
lcc
seoul
specif
bind
detect
use
biotinyl
antimous
igg
follow
peroxidasealkalin
phosphatas
streptavidin
combin
nitro
blue
tetrazolium
chlorid
nbt
phosphat
bcip
substrat
multipot
tss
test
examin
neural
lineag
express
immunocytochem
stain
briefli
seed
onto
chamber
slide
labtek
ii
nalg
nunc
intern
rochest
ny
usa
cell
grown
neural
differenti
media
contain
fetal
bovin
serum
fb
lonza
supplement
invitrogen
day
cell
fix
paraformaldehyd
min
permeabil
incub
triton
min
block
bsa
amresco
h
cell
immunostain
follow
antibodi
patient
demograph
characterist
weight
surgic
specimen
compar
use
cell
isol
tumor
specimen
yield
spheroid
cultur
ts
complet
media
fig
immunocytochem
analysi
repres
ts
sampl
identifi
cell
express
marker
associ
stem
cell
brain
tumor
stem
cell
includ
nestin
fig
assess
multilineag
differenti
capac
tss
cultur
neurogli
differenti
media
describ
method
section
analyz
express
differenti
marker
immatur
neuron
gfap
astrocyt
mbp
oligodendrocyt
neun
matur
neuron
immunocytochem
stain
fig
gbm
specimen
ts
sampl
deriv
evalu
ihc
stain
nestin
fig
show
marker
well
express
gbm
specimen
averag
weight
fresh
specimen
mg
tsposit
group
mg
tsneg
group
fig
origin
expect
greater
weight
sampl
like
isol
tss
contrari
expect
mean
weight
tsneg
group
trend
larger
tsposit
group
although
differ
reach
statist
signific
p
thu
data
indic
associ
weight
specimen
abil
isol
tss
optim
cutoff
valu
isol
tss
determin
measur
area
roc
curv
fig
translat
optim
fresh
specimen
weight
mg
isol
tss
sensit
specif
contrast
initi
hypothesi
larger
specimen
would
associ
higher
rate
ts
isol
found
sensit
specif
ts
isol
actual
higher
specimen
weigh
less
mg
greater
mg
assum
tss
aris
subpopul
cell
respons
initi
mainten
recurr
tumor
also
commonli
thought
tsgener
cell
compris
proport
tumor
higher
proport
tsgener
cell
would
associ
aggress
tumor
previou
studi
report
signific
increas
ts
isol
rate
glioma
increas
grade
suggest
relat
hypothesi
larger
specimen
mass
would
tend
favor
increas
ts
isol
rate
test
hypothesi
howev
reveal
signific
differ
specimen
weight
tsposit
neg
group
also
found
two
group
differ
respect
clinic
characterist
molecular
factor
patholog
featur
might
influenc
ts
isol
siedel
et
al
report
tumor
sampl
size
cm
suitabl
gbm
tss
isol
author
recommend
specimen
isol
gbm
tss
suggest
weight
volum
specimen
isol
tss
kind
cancer
tsrelat
studi
provid
descript
weight
volum
fresh
specimen
ts
isol
gener
speak
report
refer
assum
thing
equal
larger
specimen
better
smaller
specimen
ts
isol
howev
studi
compar
tsneg
posit
group
establish
optim
weight
volum
ts
isol
difficult
isol
tss
efficaci
procedur
low
studi
malign
tumor
brain
organ
report
ts
isol
effici
similar
result
result
current
studi
howev
author
describ
sequenti
modif
isol
techniqu
improv
effici
gbm
patient
latter
case
improv
ts
isol
involv
fix
technic
problem
associ
stage
earli
vulner
surgic
specimen
mechan
disrupt
remov
red
blood
cell
fig
character
repres
gbm
ts
morpholog
tss
shown
phasecontrast
microscopi
origin
magnif
b
immunocytochem
stain
tss
nestin
nuclei
counterstain
dapi
origin
magnif
c
tss
grown
neural
differenti
media
immunostain
gfap
mbp
neun
origin
magnif
ihc
stain
nestin
gbm
specimen
ts
sampl
isol
show
marker
well
express
origin
magnif
gbm
specimen
fig
weight
distribut
fresh
specimen
two
group
signific
differ
weight
surgic
sampl
two
group
p
mannwhitney
test
fig
receiveroper
characterist
curv
isol
tss
optim
cutoff
valu
maxim
sensit
specif
ts
isol
iv
glioma
mg
necrot
materi
fresh
specimen
although
studi
highlight
contribut
technic
problem
isol
tss
fact
abil
isol
tss
correl
poorer
clinic
outcom
variou
type
cancer
indic
success
ts
isol
sole
determin
technic
issu
previou
report
propos
primari
gbm
tss
isol
prognost
indic
clinic
outcom
addit
author
describ
tss
isol
suppos
poor
prognost
factor
malign
glioma
current
studi
evalu
prognost
role
tss
grade
iv
glioma
ts
isol
grade
iv
glioma
significantli
relat
overal
surviv
data
shown
signific
differ
clinic
characterist
molecular
factor
patholog
featur
tsposit
tsneg
group
tabl
howev
result
could
relat
short
followup
period
month
suggest
longterm
followup
cohort
need
assess
prognost
role
ts
isol
patient
grade
iv
glioma
concern
surgic
procedur
use
collect
fresh
specimen
affect
ts
isol
author
report
surgic
procedur
help
tss
exit
quiescenc
induc
format
tss
analysi
consequ
hand
surgic
resect
tissu
vulner
rapid
ischem
degen
alter
thu
optim
condit
includ
rapid
transfer
specimen
follow
surgic
resect
remov
red
blood
cell
necrot
materi
appropri
environ
growth
requir
isol
tss
fresh
surgic
specimen
laboratori
ongo
effort
develop
optim
condit
isol
ts
rna
sequenc
gene
express
array
could
help
valid
new
ts
marker
target
howev
genom
analys
necessari
establish
transcript
factor
might
influenc
ts
isol
perform
context
shown
function
inhibit
malign
glioma
prevent
ts
format
vitro
imped
tumorigenesi
vivo
studi
sought
determin
whether
abil
isol
tss
differ
depend
weight
specimen
howev
studi
regard
transcript
factor
necessari
ts
isol
need
studi
specimen
weight
mg
isol
tss
maxim
sensit
specif
result
littl
similar
valu
report
author
ideal
specimen
would
subdivid
variou
size
cultur
one
specimen
would
procur
singl
patient
howev
actual
practic
oper
room
set
impos
limit
specimen
collect
tri
collect
specimen
minimum
red
blood
cell
necrot
materi
made
difficult
gather
specimen
differ
size
patient
therefor
emphas
absenc
signific
differ
demograph
clinic
characterist
two
group
use
roc
curv
statist
process
analysi
data
yield
area
roc
curv
demonstr
poor
discriminatori
abil
isol
tss
howev
mg
fresh
specimen
prove
optim
studi
summari
data
show
signific
differ
weight
tsposit
tsneg
group
clearli
rule
sizeweight
sampl
determin
factor
success
ts
isol
studi
suggest
method
improv
effici
ts
isol
addit
stagespecif
technic
modif
futur
studi
use
larger
number
case
warrant
address
relationship
amount
fresh
specimen
ts
isol
rate
initi
hypothesi
larger
amount
specimen
would
translat
higher
rate
ts
isol
prove
incorrect
instead
found
relationship
weight
specimen
ts
isol
rate
moreov
data
suggest
mg
fresh
specimen
optim
isol
ts
maxim
sensit
specif
result
studi
could
provid
use
technic
inform
cellular
immort
patient
grade
iv
glioma
author
contribut
sgk
supervis
develop
work
gave
preciou
advic
final
approv
articl
jk
jhl
sjl
ymh
perform
experi
data
analysi
kss
perform
data
analysi
interpret
result
manuscript
write
revis
manuscript
shp
approv
statist
result
shk
approv
patholog
data
thr
jhm
ehk
shk
jhc
perform
acquisit
data
author
read
approv
final
manuscript
